Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2023
Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic ProtectionMaria Vinokurova, Maria Elisa Lopes-Pires, Neringa Cypaite, et al.
Scientific Reports|February 23, 2021
Studies on metal-organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertensionNura A Mohamed, Haissam Abou-Saleh, Yu Kameno, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 28, 2025
Fibroblast Cyclo-Oxygenase-2 Associated With the Kidney Restrains Methylarginines and Thrombosis: Relevance to Cardiovascular Side Effects of Non-Steroidal Anti-Inflammatory DrugsMaria E Lopes-Pires, Fisnik Shala, Ugo Soffientini, et al.
Cardiovascular Research|November 6, 2019
Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axisNicholas S Kirkby, Joan Raouf, Blerina Ahmetaj-Shala, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Circulation Research|January 4, 2013
Circulating microRNAs as novel biomarkers for platelet activationPeter Willeit, Anna Zampetaki, Katarzyna Dudek, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2018
Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator PathwayNicholas S Kirkby, Walkyria Sampaio, Gisele Etelvino, et al.
Journal of Cardiovascular Translational Research|March 11, 2016
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial HypertensionNura A Mohamed, Blerina Ahmetaj-Shala, Lucie Duluc, et al.
Blood|January 11, 2014
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assayMarie Lordkipanidzé, Gillian C Lowe, Nicholas S Kirkby, et al.
Kidney International Reports|June 7, 2023
Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and ManPlinio Ferreira, Ricky Vaja, Maria Lopes-Pires, et al.
Pageof 9